Precision Oncology: Emerging Technologies & Implementation

January 12-15, 2025 | Beaver Run Conference Center, Breckenridge, CO, United States
Scientific Organizers: John D. Carpten, David Solit and Chanita Hughes-Halbert

  In Person
  On Demand

January 12-15, 2025 | Beaver Run Conference Center, Breckenridge, CO, United States
Scientific Organizers: John D. Carpten, David Solit and Chanita Hughes-Halbert

Available Formats:   = In Person     = On Demand
Sunday, January 12, 2025
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Monday, January 13, 2025
Breakfast
7:00–8:00 AM
Welcome and Keynote Address
8:00–9:00 AM
Elaine R Mardis, Nationwide Children's Hospital
Novel Cancer Targets for Common and Rare Cancers
Targeted Therapeutics
9:00–11:15 AM
Frank McCormick, University of California, San Francisco
Targeting Ras in Human Cancer
Christine Lovly, Vanderbilt University
Sensitivity and Resistance to Kinase Inhibitors in Cancer
Lillian L. Siu, Princess Margaret Cancer Centre
Targeted Cytotoxics: Advances in Antibody Drug Conjugates
Short Talk(s) Chosen from Chosen fro Abstracts
Coffee Break
9:30–9:50 AM
Poster Setup
11:15–1:00 PM
On Own for Lunch
11:15–5:00 PM
Poster Viewing
1:00–10:00 PM
Panel Discussion: FDA
2:30–4:30 PM
Coffee Available
4:30–5:00 PM
Clinical Trial Advances/Insights/Design
5:00–7:00 PM
David Solit, Memorial Sloan Kettering Cancer Center
Lessons from the Study of Exceptional Responders
Vivek Subbiah, Sarah Cannon Research Institute
New Clinical Trial Designs for the Precision Medicine Era
Patricia LoRusso, Yale School of Medicine
Expanding Clinical Research Innovations into the Community
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Tuesday, January 14, 2025
Breakfast
7:00–8:00 AM
Precision Oncology and Disparities (Implementation and Discovery)
8:00–11:00 AM
Rick Kittles, Morehouse School of Medicine
Ancestry Informative Markers and Cancer Risk and Outcomes
Clayton C. Yates, Johns Hopkins School of Medicine
Using Precision Oncology to Support Innovation in Prostate Cancer Equity
Chanita Hughes-Halbert, University of Southern California
Intersection between Social and Biological Risk Factors on the Pathway to Cancer Health Equity
Rizwana Mia, South African Medical Research Council
Precision Oncology disparities in South Africa
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Poster Setup
11:00–1:00 PM
Poster Viewing
1:00–10:00 PM
Workshop 1: Late-Breaking research presentations selected from abstract submissions
1:30–3:15 PM
Short Talk(s) Chosen from Abstracts
Career Roundtable
3:30–4:30 PM
Coffee Available
4:30–5:00 PM
Precision Immuno-oncology / Overcoming Immune Evasion Through Combination Therapies
5:00–7:00 PM
Padmanee Sharma, University of Texas MD Anderson Cancer Center
Advancing Immune Checkpoint Targets in Cancer
Marta Luksza,  Icahn School of Medicine at Mount Sinai
Novel Computational Methods to Define Immunotherapy Sensitivity
Alona Sosinsky, Genomics England
Integrating Genome Sequencing into Clinical Practice for Cancer Patients
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Wednesday, January 15, 2025
Breakfast
7:00–8:00 AM
Technologies for Biomarker Discovery (Discovery Through Application in the Clinic)
8:00–11:00 AM
John D. Carpten, City of Hope Cancer Center
Assessing the Tumor and Immune Microenvironment Using Spatial Transcriptomics
Speaker to be Announced
Christina Curtis, Stanford University
Integrating Systems Biology in Precision Oncology
Colin D. Weekes, Massachusetts General Hospital
Harnessing Tumor Plasticity for Therapeutic Intent
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Workshop 2: Health Equity
2:30–4:30 PM
Coffee Available
4:30–5:00 PM
Data Science, Informatics, AI & Machine Learning
5:00–6:45 PM
David Craig, City of Hope
Informatics Strategies for Incorporating Genetic Ancestry in Precision Oncology
Benjamin Greenbaum, Memorial Sloan Kettering Cancer Center
Predicting Immunogenic Neoantigens in Cancer
Eliezer M. Van Allen, Dana-Farber Cancer Institute
Computational Approaches to Identify Mechanisms of Immunotherapy Response
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
6:45–7:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Cash Bar
8:00–11:00 PM
Entertainment
8:00–11:00 PM
Thursday, January 16, 2025
Departure
12:00–11:59 PM

Subscribe for Updates